Skip to content
Methodology
All entries for: Resolute Science Inc.
October 16, 2025
Resolute Science Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of soft tissue sarcomas
Disease Area:
Rare Diseases
Source
Scroll to Top
